Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3′,4′-dihydroxyflavonol and quercetin

Platelets

Volumn 24, Issue 8, 2013, Pages 594-604

  Mosawy, Sapha ^a,b   Jackson, Denise E ^a,b   Woodman, Owen L ^a,b   Linden, Matthew D ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b RMIT UNIVERSITY   (Australia)

Author keywords

arterial thrombosis; flavonols; Granule inhibition; platelets

Indexed keywords

3',4' DIHYDROXYFLAVONOL; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; BETA3 INTEGRIN; COLLAGEN; DUAL SPECIFICITY PHOSPHATASE 2; FIBRINOGEN; FIBRINOGEN RECEPTOR; FLAVONOL DERIVATIVE; PADGEM PROTEIN; QUERCETIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAROTID ARTERY INJURY; CAROTID ARTERY THROMBOSIS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; EXOCYTOSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; UPREGULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIOXIDANTS; ARTERIES; BLOOD PLATELETS; CYTOPLASMIC GRANULES; EXOCYTOSIS; FIBRINOGEN; FLAVONOLS; HUMANS; MICE; P-SELECTIN; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN BINDING; QUERCETIN; QUINACRINE; REGIONAL BLOOD FLOW; THROMBOSIS;

EID: 84885939237     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2012.749396     Document Type: Article

References (46)

1. Anjaneyulu M, Chopra K. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 2004;31(4):244-248.
2. Engler MB, Engler MM. The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr Rev 2006;64(3):109-118.
3. Perez-Vizcaino F, Duarte J. Flavonols and cardiovascular disease. Mol Aspects Med 2010;31(6):478-494.
4. Woodman OL, Chan ECH. Vascular and anti-oxidant actions of flavonols and flavones. Clin Exp Pharmacol Physiol 2004;31(11):786-790.
5. Hollman PCH, Feskens EJM, Katan MB. Tea flavonols in cardiovascular disease and cancer epidemiology. Proc Soc Exp Biol Med 1999;220:198-202.
6. Mladenka P, Zatloukalová L, Filipský T, Hrdina R. Cardiovascular effects of flavonoids are not caused only by direct antioxidant activity. Free Radical Biol Med 2010;49(6):963-975.
7. Erdman Jr JW, Carson L, Kwik-Uribe C, Evans EM, Allen RR. Effects of cocoa flavanols on risk factors for cardiovascular disease. Asia Pac J Clin Nutr 2008;17(Suppl. 1):284-287.
8. Geleijnse JM, Launer LJ, van der Kuip DA, Hofman A, Witteman JC. Inverse association of tea and flavonoid intakes with incident myocardial infarction: The Rotterdam Study. Am J Clin Nutr 2002;75(5):880-886.
9. Pietta PG. Flavonoids as antioxidants. J Nat Prod 2000;63(7):1035-1042.
10. Woodman OL, Malakul W. 30,40-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta. Life Sci 2009;85(1-2):54-59.
11. Ajay M, Achike FI, Mustafa AM, Mustafa MR. Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 2006;73(1):1-7.
12. Woodman OL, Meeker WF, Boujaoude M. Vasorelaxant and antioxidant activity of flavonols and flavones: Structure- activity relationships. J Cardiovasc Pharmacol 2005;46(3): 302-309.
13. Sheu JR, Hsiao G, Chou PH, Shen MY, Chou DS. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. J Agric Food Chem 2004;52(14):4414-4418.
14. Chen Y, Deuster P. Comparison of quercetin and dihydroquercetin: Antioxidant-independent actions on erythrocyte and platelet membrane. Chem Biol Interact 2009;182(1):7-12.
15. Raghavendra RH, Naidu KA. Spice active principles as the inhibitors of human platelet aggregation and thromboxane biosynthesis. Prostaglandins Leukot Essent Fatty Acids 2009;81(1):73-78.
16. Wright B, Moraes LA, Kemp CF, Mullen W, Crozier A, Lovegrove JA, Gibbins JM. A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids. Br J Pharmacol 2010;159(6):1312-1325.
17. Jasuja R, Passam FH, Kennedy DR, Kim SH, van Hessem L, Lin L, Bowley SR, Joshi SS, Dilks JR, Furie B, et al. Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents. J Clin Invest 2012;122(6):2104-2113.
18. Guerrero JA, Lozano ML, Castillo J, Benavente-Garcia O, Vicente V, Rivera J. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J Thromb Haemost 2005;3(2):369-376.
19. Hubbard GP, Stevens JM, Cicmil M, Sage T, Jordan PA, Williams CM, Lovegrove JA, Gibbins JM. Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway. J Thromb Haemost 2003;1(5):1079-1088.
20. Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM. Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost 2004;2(12):2138-2145.
21. Navarro-Nunez L, Rivera J, Guerrero JA, Martinez C, Vicente V, Lozano ML. Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR(1) and PAR(4) in platelets. Br J Pharmacol 2009;158(6):1548-1556.
22. Beretz A, Stierle A, Anton R, Cazenave J-P. Role of cyclic AMP in the inhibition of human platelet aggregation by quercetin, a flavonoid that potentiates the effect of prostacyclin. Biochem Pharmacol 1981;31:3597-3600.
23. Guerrero JA, Navarro-Nunez L, Lozano ML, Martinez C, Vicente V, Gibbins JM, Rivera J. Flavonoids inhibit the platelet TxA(2) signalling pathway and antagonize TxA(2) receptors (TP) in platelets and smooth muscle cells. Br J Clin Pharmacol 2007;64(2):133-144.
24. Wright B, Moraes LA, Kemp CF, Mullen W, Crozier A, Lovegrove JA, Gibbins JM. A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids. Br J Pharmacol 2010;159(6):1312-1325.
25. Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release. Blood 1993;82(2):505-512.
26. Chan EC, Pannangpetch P, Woodman OL. Relaxation to flavones and flavonols in rat isolated thoracic aorta: Mechanism of action and structure-activity relationships. J Cardiovasc Pharmacol 2000;35(2):326-333.
27. Wang S, Dusting GJ, May CN, Woodman OL. Dihydroxyflavonol reduces infarct size and injury associated with myocardial ischaemia and reperfusion in sheep. Br J Pharmacol 2004;142(3):443-452.
28. Wang S, Thomas CJ, Dusting GJ, Woodman OL, May CN. 30,40- Dihydroxyflavonol improves post-ischaemic coronary endothelial function following 7 days reperfusion in sheep. Eur J Pharmacol 2009;624(1-3):31-37.
29. Thomas CJ, Ng DC, Patsikatheodorou N, Limengka Y, Lee MW, Darby IA, Woodman OL, May CN. Cardioprotection from ischaemia-reperfusion injury by a novel Flavonol that reduces activation of p38 MAPK. Eur J Pharmacol 2011;658(2-3):160-167.
30. Linden MD, Frelinger 3rd AL, Barnard MR, Przyklenk K, Furman MI, Michelson AD. Application of flow cytometry to platelet disorders. Semin Thromb Hemost 2004;30(5):501-511.
31. Krueger LA, Barnard MR, Frelinger III AL, Furman MI, Michelson AD. Immunophenotypic analysis of platelets. In: Robinson JP, Darzynkiewicz Z, Dean PN, Hibbs AR, Orfao A, Rabinovitch PS, and Wheeless LL, editors. Current protocols in cytometry. Vol. 1. New York, NY: Wiley; 2002. pp 06.10.01-06.10.17.
32. Linden MD, Furman MI, Frelinger 3rd AL, Fox ML, Barnard MR, Li Y, Przyklenk K, Michelson AD. Indices of platelet activation and the stability of coronary artery disease. J Thromb Haemost 2007;5(4):761-765.
33. Linden MD, Whittaker P, Frelinger 3rd AL, Barnard MR, Michelson AD, Przyklenk K. Preconditioning ischemia attenuates molecular indices of platelet activation-aggregation. J Thromb Haemost 2006;4(12):2670-2677.
34. Wall JE, Buijs-Wilts M, Arnold JT, Wang W, White MM, Jennings LK, Jackson CW. A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents. Br J Haematol 1995;89(2):380-385.
35. Cole GM, Galasko D, Shapiro IP, Saitoh T. Stimulated platelets release amyloid beta-protein precursor. Biochem Biophys Res Commun 1990;170(1):288-295.
36. Orlowski E, Chand R, Yip J, Wong C, Goschnick MW, Wright MD, Ashman LK, Jackson DE. A platelet tetraspanin superfamily member, CD151, is required for regulation of thrombus growth and stability in vivo. J Thromb Haemost 2009;7(12):2074-2084.
37. Ren Q, Ye S, Whiteheart SW. The platelet release reaction: Just when you thought platelet secretion was simple. Curr Opin Hematol 2008;15(5):537-541.
38. Lemons PP, Chen D, Bernstein AM, Bennett MK, Whiteheart SW. Regulated secretion in platelets: Identification of elements of the platelet exocytosis machinery. Blood 1997;90(4):1490-1500.
39. Italiano Jr JE, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, Ryeom S, Folkman J, Klement GL. Angiogenesis is regulated by a novel mechanism: Pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008;111(3):1227-1233.
40. van Nispen tot Pannerden H, de Haas F, Geerts W, Posthuma G, van Dijk S, Heijnen HF. The platelet interior revisited: Electron tomography reveals tubular alpha-granule subtypes. Blood 2010;116(7):1147-1156.
41. Reed GL. Platelet secretion. In: Michelson AD, editor. Platelets. San Diego, CA: Academic Press; 2002. pp 181-195.
42. Yin H, Stojanovic A, Hay N, Du X. The role of Akt in the signaling pathway of the glycoprotein Ib-IX induced platelet activation. Blood 2008;111(2):658-665.
43. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Rémésy C, Chap H, Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 1997;53(11):1649-1657.
44. Navarro-Nunez L, Lozano ML, Martinez C, Vicente V, Rivera J. Effect of quercetin on platelet spreading on collagen and fibrinogen and on multiple platelet kinases. Fitoterapia 2010;81(2):75-80.
45. FitzGerald GA. Mechanisms of platelet activation: Thromboxane A2 as an amplifying signal for other agonists. Am J Cardiol 1991;68(7):11B-15B.
46. Leo CH, Hart JL, Woodman OL. 30,40-Dihydroxyflavonol reduces superoxide and improves nitric oxide function in diabetic rat mesenteric arteries. PLoS One 2011;6(6):e20813.